Nörometabolik Hastalıklara Giriş
Özet
Nörometabolik hastalıklar, vücuttaki enzim veya vitamin eksiklikleri ya da işlev bozuklukları nedeniyle beyin gelişimini bozan ve toksik metabolit birikimine yol açan kalıtsal bozukluklardır. Bu hastalıklar, özellikle çocuklarda nörogelişimsel gecikme, motor bozukluklar, epilepsi ve zihinsel gerilik gibi çeşitli nörolojik bulgularla kendini gösterir. Klinik tanı; dikkatli değerlendirme, görüntüleme çalışmaları ve multisistemik tutulumun (görme, işitme, karaciğer, kalp vb.) analizi ile mümkün olmaktadır. Tedavi edilebilir durumların erken teşhisi, kalıcı beyin hasarını önlemede kritik bir öneme sahiptir.
Neurometabolic diseases are inherited disorders characterized by enzyme or vitamin deficiencies or dysfunctions that impair brain development and lead to the accumulation of toxic metabolites. These conditions typically manifest in children through various neurological symptoms, including neurodevelopmental delays, motor disturbances, epilepsy, and intellectual disability. Clinical diagnosis is achieved through careful assessment, neuroimaging studies, and the analysis of multisystem involvement, such as visual, auditory, hepatic, or cardiac dysfunction. Early identification of treatable metabolic conditions is critical for preventing permanent brain damage.
Referanslar
Karimzadeh P. Approach to neurometabolic diseases from a pediatric neurological point of view. Iran J Child Neurol. 2015;9(1):1-16.
Neurologic syndrome. In: A clinical Guide to Inherited Metabolic Diseases. Clarke JTR, editör. Cambridge University Press. Newyork. 2006; 28-89.
Pediatric Neurometabolic Disorders. In: Neurology Study Guide. New York; Springer: p. 2005;217-224.
Saudubray JM. Neurometabolic disorders. J Inherit Metab Dis. 2009; 32: 595-6.
García-Cazorla A, Wolf NI, Mochel F, Hoffmann GF. Neurological Disease. In: Inherited Metabolic Diseases A Clinical Approach Second Edition. Hoffmann GF, Zschocke J, Nyhan WL, editörler. Berlin Heidelberg: Springer-Verlag; 2017. p.251-92.
Vaillend C, Poirier R, Larroche S. Genes, plasticity and mental retardation. Behav Brain Res. 2008; 192: 88-105.
Ramocki MB, Zoghbi HY. Failure of neuronal homeostasis results in common neuropasychiatric phenotypes. Nature. 2008; 455: 912-8.
Stephen G, Kalhler C, Fahey M. Metabolic disorders and mental retardation. Am J Med Genet C Semin Med Genet. 2003; 117C: 31–41.
Garcı´a-Cazorla A, Wolf NI, Serrano M et al. Mental retardation and inborn errors of metabolism. J Inherit Metab Dis. 2009; 32: 597-608.
Stromberger C, Bodamer OA, Sto¨ckler-Ipsiroglu S. Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis. 2003; 26: 299-308.
Knerr I, Gibson M, Jakobs, C, Pearl PL. Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients. CNS Spectr. 2008; 13(7): 598-605.
Gitiaux C, Ceballos-Picot I, Marie S et al. Misleading behavioural phenotype with adenylosuccinate lyase deficiency. Eur J Hum Genet. 2009; 17(1): 133-6.
Krasnewich D, O_Brien K, Sparks S. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia). Am J Med Genet C Semin Med Genet. 2007;145C(3): 302-6.
Pe´ rez-Duen˜ as B, Garcı´a-Cazorla A, Pineda M et al. Longterm evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. Eur J Paediatr Neurol 2009;13: 444–51.
Malm D, Pantel J, Linaker OM. Psychiatric symptoms in alpha-mannosidosis. J Intellect Disabil Res. 2005; 49(11): 865-87.
Gordon N. Sjo¨ egren–Larsson syndrome. Dev Med Child Neurol. 2007; 49: 152-4.
Garcı´a-Cazorla A, Wolf NI, Serrano M et al. Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis. 2009; 32: 618-629.
Poretti A, Wolf NI, Boltshauser E. Differential diagnosis of cerebellar atrophy in childhood. Eur J Paediatr Neurol. 2008; 12(3):155-167.
Prasad A, Greenberg C, Prasad C. Ataxia with identified genetic and biochemical defects. 2005. Erişim tarihi: 01 Haziran 2021. Geneclinics. http://www.emedicine.com/neuro/topic556.htm.
Ferna´ ndez-Alvarez E, General concepts In: Ferna´ ndez-Alvarez E, Aicardi J (eds) Movement disorders in children. London: MacKeith Press; 2001. p 1-23.
Assmann B, Surtees R, Hoffmann GF. Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol. 2003; 54(Suppl 6):S18-24.
Sedel F, Barnerias C, Dubourg O, Desguerres I, Lyon-Caen O, Saudubray JM. Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis. 2007; 30: 642-653.
Mitchell G, Larochelle J, Lambert M et al. Neurologic crises in hereditary tyrosinemia. N Engl J Med. 1990;322:432-7.
Debray FG, Lambert M, Vanasse M et al. Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency. Eur J Pediatr. 2006; 165:462–466.
Messing R, Simon R. Seizures as a manifestation of systemic disease. Neurol Clin. 1986; 4: 563-584.
Finsterer J, Mahjoub, SZ. Presentation of adult mitochondrial epilepsy. Seizure. 2013; 22: 119-123.
Gupta N, Kabra M, Haberle J. Mutation analysis of Indian patients with urea cycle defects. Indian Pediatr. 2012; 49: 585-6.
Eeg-Olofsson O, Zhang WW, Olsson Y, Jagell, S, Hagenfeldt L. D-2-hydroxyglutaric aciduria with cerebral, vascular, and muscular abnormalities in a 14-year-old boy. J. Child Neurol. 2000; 15: 488-492.
Teksam O, Yurdakok M, Coskun, T. Molybdenum cofactor deficiency presenting with severe metabolic acidosis and intracranial hemorrhage. J. Child Neurol. 2005; 20: 155-7.
Pro S, Randi F, Pulitano P, Vicenzini E, Mecarelli O. Non-convulsive status epilepticus characterised exclusively by a language disorder induced by non-ketotic hyperglycaemia. Epileptic Disord. 2011; 13: 193-6.
Korman SH, Gutman A. Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia). Dev Med Child Neurol. 2002; 44: 712-720.
Pearl PL, Shukla L, Theodore WH, Jakobs C, Gibson MK. Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. Brain Dev. 2011; 33: 796-805.
Lin Lin Lee V, Kar Meng Choo B, Chung YS, P Kundap U, Kumari Y, Shaikh MF. Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review. Int J Mol Sci. 2018;19(3):871.
Burin MG, Scholz AP, Gus R, et al. Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn. 2004;24: 653-7.
Dhamija R, Patterson MC, Wirrell EC. Epilepsy in children--when should we think neurometabolic disease? Child Neurol. 2012;27(5):663-671.
